Viewpoints: FDA Regulatory Considerations on Approvals for Artificial Intelligence

Episode 20 – Healthcare Tech: How Will the FDA Regulatory Framework Adapt to AI?Подробнее

Connected With Latham: Healthcare Tech – How Will the FDA Regulatory Framework Adapt to AI?Подробнее

AI/Machine Learning: Regulation, Development, and Real-World Performance EvaluationПодробнее

FDA Regulatory Framework for AI & ML-Enabled Medical DevicesПодробнее

How AI is Revolutionizing EvaluationsПодробнее

Navigating FDA Regulations for SaMD AI and Machine Learning with Adam ForesmanПодробнее

Guideways.ai FDA approval strategy AI agent for MedtechПодробнее

AIMI Symposium 2020 - Session 2: Regulatory Considerations for AI in HealthcareПодробнее

FDA Regulation of Artificial IntelligenceПодробнее

Unlocking Success: FDA Regulatory Strategies for AgeTech Devices and AIПодробнее

FDA Predetermined Change Control Plan (PCCP) Guidance for Artificial Intelligence (AI)Подробнее

Amy Abernethy on ways AI can improve clinical trials #WMIF19Подробнее

FDA Regulation of Artificial Intelligence Machine LearningПодробнее

Software Thought Leadership Series - FDA REGULATION OF CLINICAL DECISION SUPPORT SOFTWARE AND AI/MLПодробнее

FDA's Sentinel Initiative - Pharmacovigilance 2020Подробнее

The Current State of 950 FDA-Approved AI-based Medical Devices - The Medical FuturistПодробнее

Tala Fakhouri - Responsive Regulation of AI in Drug DevelopmentПодробнее

Decision Summary: Lessons from the first FDA Approval of an AI Tool in Diagnostic PathologyПодробнее

Zach Harned - FDA, AI/ML, and Medical DevicesПодробнее